top of page

Why VOID

The space between matters.

Within tissues, cells are surrounded by an extracellular matrix, or ECM, a complex network of proteins, polysaccharides and other biological molecules. It provides structure, signals and the environment that helps cells organise and function.

VOID begins with this space. We are developing technologies to make biological matrix environments more defined, controllable and reproducible.

What We Are Building

Codex Image 18 Sept 2026, 13_01_56.png

A new infrastructure for biofabrication.
The Inkfinity™ Platform brings together defined extracellular matrix materials, intelligent formulation and standardised preparation in one connected system, creating a scalable foundation for how biological matrices are designed, prepared and used.

Our Direction 

One platform.

Three directions.

The Inkfinity™ Platform is designed to grow in three directions: expanding where biofabrication can operate, advancing its path towards clinical translation, and increasing its ability to adapt to individual biology.

fh233f.jpg

X · Deployment

Extending biofabrication from the laboratory to clinical, remote and ultimately off Earth environments through standardised, deployable systems.

IMG_3476.HEIC

Y · Translation

Building a connected pathway from Research Use Only workflows towards clinical application through a platform designed for future medical grade translation.

IMG_0340_edited.jpg

Z · Personalisation

Enabling modular biomaterial formulations to adapt across tissues and, ultimately, support patient specific regenerative applications.

X  

Deployment

Bench. Bedside. Beyond.

From controlled laboratories to the most demanding environments.

Different tissues require different matrix environments. VOID is building towards modular biomaterial systems that can be formulated for different biological contexts, creating a pathway from defined tissue specific matrices towards increasingly personalised applications.

Y

Translation

Research. Translation. Medicine.

Built to move forward.

Biofabrication today relies on specialised facilities, controlled conditions and complex workflows. VOID is building towards a more deployable approach, combining standardised biomaterials, controlled preparation and intelligent formulation within one connected platform.

The goal is to extend reproducible biofabrication from the research bench towards clinical, remote and ultimately off Earth environments.

Z

Personalisation

Tissue. Patient. Personalised.

Designed to adapt.

Different tissues require different matrix environments. VOID is building towards modular biomaterial systems that can be formulated for different biological contexts, creating a pathway from defined tissue specific matrices towards increasingly personalised applications.

Three Directions. One Foundation.

Deployment, translation and personalisation represent different directions for the future of biofabrication. Inkfinity™ is being built as the common foundation connecting them, starting with greater control over the materials and processes we use today.

hulh_edited.jpg

Big things have small beginnings.

Biofabrication is being rebuilt from the ground up. We are looking for people who understand why that matters. If you are working at the frontier of biomaterials, clinical translation, or space medicine, this is where the work is being done.

bottom of page